Investor Presentaiton slide image

Investor Presentaiton

13 Adjusted EBITDA Three months ended March 31, 2023 2022 (in millions) Net Income (Loss) Depreciation and amortization Interest expense Loss on sale of assets, net Non-recurring professional fees, M&A integration and restructuring expense Patent litigation settlement Non-cash stock compensation Other income, net $ (38.0) $ 5.7 45.5 14.9 44.4 7.4 0.4 5.8 11.7 45.4 5.4 5.7 (1.2) (8.7) Income tax expense (benefit) Adjusted EBITDA (12.6) (0.2) $ 65.2 $ 66.4
View entire presentation